These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2056253)

  • 21. Which thymic hormone?
    Lancet; 1983 Jun; 1(8337):1309-11. PubMed ID: 6134098
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in histamine metabolism during treatment of hepatitis B patients with splenin].
    Mitchenko IK; Slobodianiuk MI; Degtiarenko OM; Shevchenko AV; Tiuleneva GV
    Vrach Delo; 1984 May; (5):120-1. PubMed ID: 6741074
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the problem of recognizing viral hepatitis as an occupational disease].
    Reikowski H
    Dtsch Med Wochenschr; 1965 Nov; 90(47):2099-104. PubMed ID: 5844786
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of splenin on the blood T-lymphocyte count in workers in the manufacture of amino acids and antibiotics].
    Gordienko VE
    Vrach Delo; 1984 Oct; (10):101-4. PubMed ID: 6240160
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymus-derived peptides for chronic viral hepatitis: have they fulfilled their promise?
    Di Bisceglie AM
    Dig Dis; 1996; 14(6):331-3. PubMed ID: 9030464
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
    Juszczyk J
    Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response].
    Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ
    Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B surface antigen (HbsAg): (a survey of hospital staff in Zambia).
    Bhagwat GP; Parmar S
    Med J Zambia; 1983 Oct; 17(4):106-8. PubMed ID: 6680555
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis B among dentists in the Kyobashi district].
    Shiyo; 1983 Nov; 31(11):38-42. PubMed ID: 6593520
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapy using T-activin in chronic viral hepatitis B in children].
    Nisevich NI; Uchaĭkin VF; Arion VIa; Cherednichenko TV; Shkliar GM
    Sov Med; 1986; (12):55-9. PubMed ID: 3563706
    [No Abstract]   [Full Text] [Related]  

  • 32. Human serum thymic factor in ataxia-telangiectasia.
    Mori PG; Tonini GP; Bisogni MC; DeBernardi B; Pasino M
    N Engl J Med; 1978 Mar; 298(11):628-9. PubMed ID: 628379
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis B markers in the personnel of clinical-diagnostic laboratories].
    Platonov SA; Orgel' MIa; Matoshko GV; Goroshnikov SB; Kutsenko IM
    Vrach Delo; 1981 Nov; (11):107-10. PubMed ID: 7342426
    [No Abstract]   [Full Text] [Related]  

  • 34. [Humoral immunity in hepatitis A and B among workers in an infectious disease hospital].
    Juszczyk J; Bereszyńska I; Kryska A
    Pol Tyg Lek; 1985 Jan; 40(3):61-4. PubMed ID: 3982996
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis B: the incidence of carriers and the initial experience of mass vaccination in the police].
    Cioli S; Cordelli A; Sardone D; Giannelli G; Lalli CG; Maresca A; Pioda GB; Lanzetta BM; D'Annibali E
    G Ital Med Lav; 1990; 12(2-4):81-5; discussion 85-6. PubMed ID: 2152608
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical markers of compliance in the Physicians' Health Study.
    Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
    Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B among physicians in the county of Vejle].
    Rothgardt NP; Schouenborg PO; Foldspang A
    Ugeskr Laeger; 1987 Aug; 149(34):2282-4. PubMed ID: 3451455
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical characteristics of chronic hepatitis B in children and the principles of its staged treatment].
    Gol'zand IV; Murav'eva NN; Goriacheva LG; Bulovskaia LN; Gorvat NA
    Pediatriia; 1987; (3):40-4. PubMed ID: 3601536
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increased prevalence of hepatitis B markers in persons caring for HBSAG carriers].
    Ahman M; Alexandersson R; Magnius L
    Lakartidningen; 1990 Jan; 87(3):110-2. PubMed ID: 2299915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.